Callan JMB Expects Up to $15 Million in Oral Thin-Film Revenue in First 18 Months of Operation

PUBT · 11/02 13:06
Callan JMB Expects Up to $15 Million in Oral Thin-Film Revenue in First 18 Months of Operation
  • Callan JMB expects up to $15 million in oral thin-film manufacturing revenue during its first 18 months of operation following equipment qualification.
  • The QuickStrip production line from Rapid Dose Therapeutics has arrived for installation at its Texas facility.
  • Neither this project nor the previously announced IV bag manufacturing facility requires additional capital raising.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Callan JMB Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611020800PRIMZONEFULLFEED9867760) on November 02, 2026, and is solely responsible for the information contained therein.